GlassScriptPhysician profile
Jaylon G Snyder
NPI 1427726991
$664.99
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.39 · 2022: $416 · 2023: $213 · 2024: $18.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $167 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $167.20 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $242.95 | 2022-2023 | Erleada |
| Astrazeneca Pharmaceuticals LP | $79.28 | 2022-2023 | Lynparza |
| Blue Earth Diagnostics | $69.30 | 2022 | |
| Astellas Pharma US INC | $65.00 | 2023 | |
| Myriad Genetic Laboratories, INC. | $58.67 | 2022-2024 | Prolaris |
| Dendreon Pharmaceuticals LLC | $52.46 | 2021-2023 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $44.34 | 2022 | |
| Sumitomo Pharma America, INC. | $20.84 | 2023 | Gemtesa |
| Medtronic, INC. | $17.90 | 2022 | |
| Antares Pharma, INC. | $14.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaylon Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.